Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study

BACKGROUND: High blood pressure is an important determinant of cardiovascular disease risk. Treated hypertensives do not attain a risk level equivalent to normotensives. This may be a consequence of suboptimal blood pressure control to which indiscriminate use of antihypertensive drugs may contribut...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Parthasarathy, Hari K, Alhashmi, Khamis, McMahon, Alex D, Struthers, Allan D, Connell, John MC, McInnes, Gordon T, Ford, Ian, MacDonald, Thomas M
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2007
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1877813/
https://ncbi.nlm.nih.gov/pubmed/17490489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-7-14
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky